These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16636304)

  • 1. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):407-11. PubMed ID: 15096652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):412-6. PubMed ID: 15096653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
    Gouni-Berthold I; Berthold HK; Gylling H; Hallikainen M; Giannakidou E; Stier S; Ko Y; Patel D; Soutar AK; Seedorf U; Mantzoros CS; Plat J; Krone W
    Atherosclerosis; 2008 May; 198(1):198-207. PubMed ID: 17980884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
    Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
    Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation.
    Chambers CM; Ness GC
    Arch Biochem Biophys; 1998 Jun; 354(2):317-22. PubMed ID: 9637742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
    Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
    Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
    Wu N; Sarna LK; Siow YL; O K
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: the concept of cholesterol buffering capacity.
    Ness GC; Chambers CM
    Proc Soc Exp Biol Med; 2000 May; 224(1):8-19. PubMed ID: 10782041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
    Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
    J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase.
    Yiu WF; Kwan PL; Wong CY; Kam TS; Chiu SM; Chan SW; Chan R
    J Food Sci; 2011 Apr; 76(3):H80-9. PubMed ID: 21535835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin.
    Nguyen LB; Shefer S; Salen G; Tint GS; Ruiz F; Bullock J
    J Lipid Res; 2001 Feb; 42(2):195-200. PubMed ID: 11181748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hepatic sterol metabolism in the rat. Parallel regulation of activity and mRNA for 7 alpha-hydroxylase but not 3-hydroxy-3-methylglutaryl-coenzyme A reductase or low density lipoprotein receptor.
    Spady DK; Cuthbert JA
    J Biol Chem; 1992 Mar; 267(8):5584-91. PubMed ID: 1544932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.